Advantage Alpha Capital Partners LP Has $2.79 Million Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Advantage Alpha Capital Partners LP lifted its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 26.4% in the 4th quarter, Holdings Channel reports. The firm owned 120,091 shares of the company’s stock after buying an additional 25,070 shares during the quarter. Advantage Alpha Capital Partners LP’s holdings in Option Care Health were worth $2,786,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Cornerstone Investment Partners LLC raised its holdings in Option Care Health by 3.6% during the fourth quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company’s stock valued at $221,000 after buying an additional 333 shares in the last quarter. UMB Bank n.a. raised its stake in shares of Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after acquiring an additional 346 shares in the last quarter. Assetmark Inc. lifted its holdings in Option Care Health by 2.0% in the 4th quarter. Assetmark Inc. now owns 24,976 shares of the company’s stock worth $579,000 after purchasing an additional 487 shares during the last quarter. Pacer Advisors Inc. grew its holdings in Option Care Health by 2.2% during the fourth quarter. Pacer Advisors Inc. now owns 25,483 shares of the company’s stock valued at $591,000 after purchasing an additional 537 shares during the last quarter. Finally, Sheets Smith Wealth Management raised its position in shares of Option Care Health by 2.4% in the fourth quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company’s stock valued at $553,000 after purchasing an additional 550 shares during the period. 98.05% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.64% of the company’s stock.

Option Care Health Stock Performance

Shares of OPCH opened at $34.58 on Monday. The firm has a market cap of $5.72 billion, a P/E ratio of 29.06, a PEG ratio of 2.30 and a beta of 1.33. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $34.85. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The firm’s 50 day moving average price is $31.84 and its two-hundred day moving average price is $28.29.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on OPCH. JMP Securities reiterated a “market outperform” rating and issued a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and boosted their price objective for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. JPMorgan Chase & Co. increased their price target on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research report on Thursday, March 6th. UBS Group started coverage on Option Care Health in a report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective for the company. Finally, Barrington Research lifted their target price on shares of Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research note on Thursday, February 27th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $33.00.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.